Stock DNA
Pharmaceuticals & Biotechnology
USD 121 Million ()
NA (Loss Making)
NA
0.00%
-0.45
-37.10%
1.37
Total Returns (Price + Dividend) 
Sera Prognostics, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
Is Sera Prognostics, Inc. technically bullish or bearish?
As of 9 September 2025, the technical trend for Sera Prognostics, Inc. has changed from mildly bearish to sideways. The current stance is neutral, with mixed signals across different indicators. The weekly MACD is mildly bullish, while the monthly MACD is bearish. The Bollinger Bands indicate a bullish signal on the weekly chart but bearish on the monthly. Moving averages are mildly bearish on the daily timeframe. The KST shows bullish momentum on both weekly and monthly charts, while Dow Theory presents a mildly bearish view weekly and mildly bullish monthly. The OBV is mildly bearish across both timeframes. In terms of performance, the stock has outperformed the S&P 500 over the past week and month, with returns of 4.23% and 34.45% respectively, compared to the S&P 500's 1.05% and 2.33%. However, year-to-date and one-year returns are significantly negative at -60.69% and -59.13%, respectively, while the ...
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Domestic Funds
Held in 20 Schemes (16.43%)
Held by 24 Foreign Institutions (3.12%)
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
YoY Growth in quarter ended Jun 2025 is 0.00% vs -100.00% in Jun 2024
YoY Growth in quarter ended Jun 2025 is 3.61% vs 20.95% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -66.67% vs 0.00% in Dec 2023
YoY Growth in year ended Dec 2024 is 9.12% vs 18.10% in Dec 2023






